Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry News Roundup

This article was originally published in The Tan Sheet

Executive Summary

Mead Johnson sales climb despite slump in China; Abbott Nutritional rides “stronger footprint”; FDA sets deadline to finalize GRAS rule; general claims need specific support in U.K.; FDA warns of drug claims; YoungYou violates GMPs; FSMA meeting slated for Nov. 13; and more TiO2 settlements under Prop 65.

You may also be interested in...



Tracking Federal Agencies’ Enforcement In Supplement Space

““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.

Tracking Federal Agencies’ Enforcement In Supplement Space

““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.

TiO2-Containing Cosmetic Powders Subject Of Prop 65 Settlements

Five marketers of cosmetic powders containing titanium dioxide particles have agreed to settle with NGO the Public Interest Alliance LLC in a case brought under California’s Proposition 65 regulation.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel